(Q67661983)

English

A soluble inhibitor of T lymphocyte function induced by HIV-1 infection of CD4+ T cells: Characterization of a cellular protein and its relationship to p15E

scientific article published on 01 July 1990

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694108%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

A soluble inhibitor of T lymphocyte function induced by HIV-1 infection of CD4+ T cells: characterization of a cellular protein and its relationship to p15E (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694108%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

A soluble inhibitor of T lymphocyte function induced by HIV-1 infection of CD4+ T cells: Characterization of a cellular protein and its relationship to p15E (English)

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

nucleocapsid proteins

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694108

31 October 2022

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

author name string

J. Laurence

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694108

31 October 2022

J. Kulkosky

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694108

31 October 2022

B. Dong

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694108

31 October 2022

E. Early

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694108

31 October 2022

R. Snyderman

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694108

31 October 2022

G. J. Cianciolo

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1694108

31 October 2022

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1694108

31 October 2022

publication date

1 July 1990

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694108%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

number of pages

16

1 reference

based on heuristic

inferred from page(s)

full work available at URL

https://api.elsevier.com/content/article/PII:000887499090031L?httpAccept=text/xml

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

https://api.elsevier.com/content/article/PII:000887499090031L?httpAccept=text/plain

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Cellular Immunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694108%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

128

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694108%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694108%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

337-352

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694108%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1126/SCIENCE.3313729

Viruses can cause disease in the absence of morphological evidence of cell injury: implication for uncovering new diseases in the future

1

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Human immunodeficiency virus infection of helper T cell clones. Early proliferative defects despite intact antigen-specific recognition and interleukin 4 secretion

3

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs

4

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Long-term cultures of HTLV-III--infected T cells: a model of cytopathology of T-cell depletion in AIDS.

7

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Induction of expression of HIV in latently or chronically infected cells

8

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4

9

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Effects of colony stimulating factors on the interaction of monocytes and the human immunodeficiency virus

10

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

The immune system in AIDS.

14

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Soluble suppressor factors in patients with acquired immune deficiency syndrome and its prodrome. Elaboration in vitro by T lymphocyte-adherent cell interactions

15

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Soluble factors inhibitory for T-cell-dependent immune responses in patients with the acquired immune deficiency syndrome and its prodromes

16

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Immunoregulatory Lymphokines of T Hybridomas from AIDS Patients: Constitutive and Inducible Suppressor Factors

17

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

PolyI.polyC12U-mediated inhibition of loss of alloantigen responsiveness viral replication in human CD4+ T cell clones exposed to human immunodeficiency virus in vitro

18

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Immunoassay for the detection and quantitation of infectious human retrovirus, lymphadenopathy-associated virus (LAV).

19

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses

20

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E

22

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Human malignant and mitogen-transformed cells contain retroviral P15E-related antigen

23

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Characterization and clinical association of antibody inhibitory to HIV reverse transcriptase activity

24

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

25

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

AIDS retrovirus induced cytopathology: giant cell formation and involvement of CD4 antigen

36

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins.

37

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Antibody to a synthetic peptide detects a conserved region of retrovirus transmembrane proteins

39

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Shedding and interspecies type sero-reactivity of the envelope glycopolypeptide gp120 of the human immunodeficiency virus

41

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Molecular biology of HIV.

42

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response.

43

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Inhibition of normal human natural killer cell activity by human immunodeficiency virus synthetic transmembrane peptides

44

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Inhibitory effect of nonviable preparations from human immunodeficiency virus 1 on inositol phospholipid metabolism

49

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Regulatory pathways governing HIV-1 replication

51

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

The effects of human immunodeficiency virus recombinant envelope glycoprotein on immune cell functions in vitro

52

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

HIV-mediated immunodepression: in vitro inhibition of T-lymphocyte proliferative response by ultraviolet-inactivated virus.

54

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Human retrovirus-related synthetic peptides inhibit T lymphocyte proliferation.

56

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Suppression of concanavalin A-induced blastogenesis by HTLV-III-infected H9 cells.

58

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Cytotoxic factors secreted by cells infected by human immunodeficiency virus type I.

59

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Human immunodeficiency virus-induced cytotoxicity for CD8 cells from some normal donors and virus-specific induction of a suppressor factor

61

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Inhibition of in vitro lymphocyte proliferation by serum from acquired immune deficiency syndrome patients depends on the ratio of cells to serum in culture

64

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Inhibition of interleukin 2 production and expression of the interleukin 2 receptor by plasma from acquired immune deficiency syndrome patients

65

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Suppression of in vitro haematopoiesis following human immunodeficiency virus infection

66

1 reference

10.1016/0008-8749(90)90031-L

https://api.crossref.org/works/10.1016/0008-8749(90)90031-L

31 October 2022

Identifiers

10.1016/0008-8749(90)90031-L

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694108%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1694108%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q67661983&oldid=1785980082"